Charles Elliott Sigal - Jul 1, 2022 Form 4 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ADAP	Option to purchase Ordinary Shares	Award	$0	+737K		$0.00	737K	Jul 1, 2022	Ordinary Shares	737K	$0.28	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The exercise price was converted from GBP0.23 based on an exchange rate of $U.S. 1.216007 to GBP1.00. The actual exercise price will be the pounds sterling amount.